Table 1 AKI episode characteristics in the before and after periods. *: AKI episodes filtered based on use of nephrotoxic medication as not all patients with AKI were using nephrotoxic medication. Only p-values are shown for outcomes related to awareness
Before (6th of April 2021 – 5th of October 2021) | After (6th of October 2021–5th of April 2022) | p-value | |
|---|---|---|---|
Episodes | 884 | 819 | |
Department at start episode - Emergency department - Hospital ward - Outpatient department | 147 (13.6%) 492 (45.6%) 245 (22.7%) | 184 (18.1%) 463 (45.6%) 172 (16.9%) | |
PCr follow up within 2 days - Emergency department - Hospital ward - Outpatient department | 500/884 (56.6%) 103/147 (70.1%) 344/492 (69.9%) 53/245 (21.6%) | 538/819 (65.7%) 155/184 (84.2%) 346/463 (74.7%) 37/172 (21.5%) | < 0.001 0.003 0.11 1.0 |
Episodes with nephrotoxic medication count(%) | |||
- Emergency department - Hospital ward - Outpatient department | 83/147 (56.5%) 341/492 (69.3%) 99/245 (40.4%) | 107/184 (58.2%) 340/463 (73.4%) 71/172 (41.3%) | |
Stop medication within 7 days* - Emergency department - Hospital ward - Outpatient department | 407/523 (77.8%) 76/83 (91.6%) 288/341 (84.5%) 43/99 (43.4%) | 442/518 (85.3%) 100/107 (93.5%) 297/340 (87.4%) 45/71 (63.4%) | 0.002 0.83 0.33 0.016 |